Conmed (CNMD) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Conmed (CNMD) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 16.91% |
| 10 | Conmed | 1.55 Bn | 1.51 Bn | 197.46 Mn | -5.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.88% |
| Mar 31, 2026 | 53.34% |
| Dec 31, 2025 | -16.17% |
| Sep 30, 2025 | -81.65% |
| Jun 30, 2025 | -17.85% |
| Mar 31, 2025 | -53.88% |
| Dec 31, 2024 | 12.25% |
| Sep 30, 2024 | 98.64% |
| Jun 30, 2024 | 57.84% |
| Mar 31, 2024 | 153.44% |
| Dec 31, 2023 | 44,731.60% |
| Sep 30, 2023 | 20.79% |
| Jun 30, 2023 | 244.62% |
| Mar 31, 2023 | -51.94% |
| Dec 31, 2022 | 99.81% |
| Sep 30, 2022 | -19.67% |
| Jun 30, 2022 | -73.58% |
| Mar 31, 2022 | 12.37% |
| Dec 31, 2021 | -373.61% |
| Sep 30, 2021 | -10.16% |